Trials
1 active
2 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Insertion of STIMULAN VG into the ulcer cavity prior to flap/primary closure.”In the company’s words, NCT06283979 on ClinicalTrials.gov
- Tested for
- Pressure Ulcer, Stage IV, Osteomyelitis
- Main trialPhase 2
- “The purpose of this trial is to assess the safety, tolerability and between-group effect size of STIMULAN VG (with debridement) and a course of systemic antibiotics to standard of care (debridement and systemic antibiotics only) for the treatment of osteomyelitis associated stage IV pressure ulcers.”In the company’s words, NCT06283979 on ClinicalTrials.gov
Coming up1
- 1 Aug 2027Phase 2 trial completes · ClinicalTrials.gov
Changes1
Last 90 days- 10 NovCompletion date moved: 2026-12-01 to 2027-08-01 · ClinicalTrials.gov NCT06283979
Trials2
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Recruiting | 1 Aug 2027 | A Randomized Controlled Phase II Trial of STIMULAN VG vs Standard of Care (SoC) for the Treatment of Osteomyelitis Associated With Stage IV Pressure Ulcers. | |
| Phase 2Completed | 22 Jun 2026 | A Feasibility Trial to Investigate the Safety and Between-group Effect Size of STIMULAN VG and Standard of Care (SoC) in Participants With Diabetic Foot Osteomyelitis |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026